Documents: ACTA and Access to Medicine

 
Name Author Size Date
Name Author Size Date
Counterfeit, Medicines and ACTAUmang Singh608.0 KiB2010.12.13
Umang Singh, Counterfeit, Medicines and ACTA (National Academy of Legal Studies and Research University Working Paper Series, 2010), available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1725072.
The Evolution of US and EU Approaches to Intellectual Property Provision Related to Public Health in Free Trade Agreements: Are They Responding to Public Health Concerns?Yi-Jen Chu470.0 KiB2010.09.17
Yi-Jen Chu, The Evolution of US and EU Approaches to Intellectual Property Provision Related to Public Health in Free Trade Agreements: Are They Responding to Public Health Concerns? (Sep. 17, 2010) (Master thesis, Munich Intellectual Property Law Center), available at http://ssrn.com/abstract=1739488.
Border Enforcement of IP Rights Against In Transit Generic Pharmaceuticals: An Analysis of Character and ConsistencyShashank P. Kumar245.4 KiB2009.04.15
Shashank P. Kumar, Border Enforcement of IP Rights Against In Transit Generic Pharmaceuticals: An Analysis of Character and Consistency, EUR. INTELL. PROP. REV. (forthcoming 2010), available at http://ssrn.com/abstract=1383067.
TRIPS, Patent Rights and Right to Health: “Price” or “Prize” for Better Access to Medicine?Mor Bakhoum376.3 KiB2009.01.31
Mor Bakhoum, TRIPS, Patent Rights and Right to Health: “Price” or “Prize” for Better Access to Medicine? (Max Planck Inst. for Intell. Prop., Competition & Tax Law Research Paper Series No. 10-17, 2009), available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1619215.
The Global Upward Ratchet, Andt-Counterfeiting And Piracy Enforcement EffortsSusan Sell240.4 KiB2008
Susan Sell, The Global Upward Ratchet, and Anti-Counterfeiting and Piracy Enforcement Efforts: The State of Play (2008), http://www.twnside.org.sg/title2/intellectual_property/development.research/SusanSellfinalversion.pdf.
Resolving The Public Health Crisis In The Developing World: Problems And Barriers Of Access To Essential MedicinesBryan Mercurio215.5 KiB2007.04.13
Bryan Mercurio, Resolving the Public Health Crisis in the Developing World: Problems and Barriers of Access to Essential Medicines, 5 NW. J INT’L HUM. RTS. 1 (2007) available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=980175.
Present Stakes Around Patent Political Economy: Legal And Economic Lessons From The Pharmaceutical Patent Rights In IndiaSamira Guennif, Julien Chaisse231.5 KiB2007.03
Samira Guennif & Julien Chaisse, Present Stakes Around Patent Political Economy: Legal And Economic Lessons From The Pharmaceutical Patent Rights In India, 2 ASIAN J. WTO & INT'L HEALTH L. AND POL. 65 (2007), available at http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1019749.
Tripping Up TRIPS Debates IP And Health In Bilateral AgreementsJean-Frederic Morin211.4 KiB2006
Jean-Frederic Morin, Tripping up TRIPS debates IP and health in bilateral agreements, 1 Int’l J. of Intell. Prop. Mgmt. 37 (2006).
Global Intellectual Property Governance, 12 Theoretical Inquiries L 349Margaret Chon203.4 KiB
Margaret Chon, Global Intellectual Property Governance, 12 THEORETICAL INQUIRIES L. 349 (2011).
Breaking PatentsDaniel Cahoy326.4 KiB
Daniel R. Cahoy, Breaking Patents, 32 MICH. J. INT’L L. 461 (2011).
Enforcing IP Rights Via EU Border RegulationsCatherine Dounis212.8 KiB
Catherine Dounis, Enforcing Intellectual Property Rights via EU Border Regulations: Inhibiting Access to Medicine or Preventing Counterfeit Medicine?, 36 BROOK. J. INT’L L. 717 (2011).
A Trade Agreement Creating Barriers To International Trade AU ILRHenning Grosse Ruse-Khan568.7 KiB
Henning Grosse Ruse-Khan, A Trade Agreement Creating Barriers to International Trade?: ACTA Border Measures and Goods in Transit (Max Planck Inst. for Intell. Prop., Competition & Tax Law Research Paper Series No. 10-10, 2010), available at http://ssrn.com/abstract=1706567.
Collateral Damage: The Impact Of ACTA And The Enforcement Agenda on the World's Poorest PeopleAndrew Rens244.0 KiB
Andrew Rens, Collateral Damage: The Impact of ACTA and the Enforcement Agenda on the World's Poorest People (Program for Information Justice and Public Policy, Research Paper No. 8, 2010), available at: http://digitalcommons.wcl.american.edu/research/8/.
TRIPs, Patents And Access To Life-Saving Drugs In The Developing WorldBrian C. Mercurio288.2 KiB
Brian C. Mercurio, TRIPS, Patents, And Access To Life-Saving Drugs In The Developing World, 8 MARQ. INTELL. PROP. L. REV. 211 (2004).
A Critical Look At The Anti-Counterfeiting Trade Agreement, 17 Rich J L & Tech 16David Quinn148.7 KiB
David M. Quinn, A Critical Look at the Anti-Counterfeiting Trade Agreement, 17 RICH. J.L. & TECH. 16 (2011).
TRIPS and the Access to Medicines CampaignSusan K. Sell3.0 MiB
Susan K. Sell, TRIPS and the Access to Medicines Campaign, 20 WIS. INT’L L.J. 481 (2002).
Six Secret (and Now Open) Fears Of ACTAPeter Yu973.8 KiB
Peter K. Yu, Six Secret (and Now Open) Fears of ACTA, 64 SMU L. REV. ____ (2011), available at http://ssrn.com/abstract=1624813.
Harmonization And Its DiscontentsAmy Kapczynski512.5 KiB
Amy Kapczynski, Harmonization and its Discontents, 97 CAL. L. REV. 1571 (2009).
The Proposed Anti-Counterfeiting Trade Agreement (ACTA): Two Tales of a TreatyCharles R. McManis1.4 MiB
Charles R. McManis, The Proposed Anti-Counterfeiting Trade Agreement (ACTA): Two Tales of a Treaty, 46 HOUS. L. REV. 1235 (2010).
ACTA: Risks Of Third Party Enforcement For Access To MedicinesBrook K. Baker216.7 KiB
Brook K. Baker, ACTA: Risks of Third Party Enforcement for Access to Medicines (Program for Information Justice and Public Policy, Research Paper No. 1, 2010), available at: http://digitalcommons.wcl.american.edu/research/1/.
ACTA And Public HealthPeter Maybarduk228.8 KiB
Peter Maybarduk, ACTA and Public Health (Program for Information Justice and Public Policy, Research Paper No. 9, 2010), available at: http://digitalcommons.wcl.american.edu/research/9/.
Unveiling Competing Patent PerspectivesCynthia M. Ho342.2 KiB
Cynthia M. Ho, Unveiling Competing Patent Perspectives, 46 HOUS. L. REV. 1047 (2009).
The National Law Review - From Trips To ACTA Establishing The Intent To Uphold Access To Medicine In The Face Of Ambiguity - 2011-04-22149.3 KiB
2011 Amir Attaran, Et Al, Why And How To Make An International Crime Of Medicine Counterfeiting, 9 J Int'l Crim Just 325160.1 KiB
Name Author Size Date
Name Author Size Date
Wyden TPP Transparency AmendmentU.S. Senate - Wyden21.5 KiB2012.03.20
Brazil Request For Consultation (05.19.10)34.9 KiB2010.05.19
Does ACTA Undermine Delinkage Of Medicine Prices And RD CostsYannik Jadot, et al.343.1 KiB2010
Form for Tabling Parliamentary Questions from Yannik Jadot, et al., Does ACTA undermine delinkage of medicine prices and R&D costs?, European Parliament (June 03, 2010).
European Parliament resolution of 10 March 2010 on the transparency and state of play of the ACTA negotiationsEuropean Parliament48.6 KiB2010
European Parliament resolution of 10 March 2010 on the transparency and state of play of the ACTA negotiations, P7_TA(2010)0058, available at http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+TA+P7-TA-2010-0058+0+DOC+XML+V0//EN.
Press Release, The Greens, European Free Alliance in the European Parliament, Anti-Counterfeiting Trade Agreement (ACTA): Centre-right MEPs write blank cheque on ACTA; vote threatens civil liberties in EUGreens/EFA28.1 KiB2010
Press Release, The Greens, European Free Alliance in the European Parliament, Anti-Counterfeiting Trade Agreement (ACTA): Centre-right MEPs write blank cheque on ACTA; vote threatens civil liberties in EU (Nov. 24, 2010), http://www.greens-efa.eu/anti-counterfeiting-trade-agreement-acta-2835.html.
European Parliament resolution of 24 November 2010 on the Anti-Counterfeiting Trade Agreement (ACTA)European Parliament45.9 KiB2010
European Parliament resolution of 24 November 2010 on the Anti-Counterfeiting Trade Agreement (ACTA), P7_TA-PROV(2010)0432, available at http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+TA+P7-TA-2010-0432+0+DOC+XML+V0//EN.
Greens/EFA calls for ACTA transparencyGreens/EFA61.3 KiB2010
Greens/EFA calls for ACTA transparency, THE GREENS | EUROPEAN FREE ALLIANCE (July 08, 2010), available at: http://www.erikjosefsson.eu/sites/default/files/Greens_call_for_ACTA_transparency.html.
Lack of safeguards in ACTA undermining access to medicinesYannik Jadot, et al.349.4 KiB2010
Form for Tabling Parliamentary Questions from Yannik Jadot, et al., Lack of safeguards in ACTA undermining access to medicines, European Parliament (June 03, 2010).
India Request To Join Consultations (06.02.10)9.4 KiB
India Request For Consultation (05.19.10)26.3 KiB
Name Author Size Date
Name Author Size Date
The Anti-Counterfeiting Trade Agreement (ACTA): An AssessmentDirectorate-General for External Policies, European Parliament980.5 KiB2011.07.11
Directorate-General for External Policies, The Anti-Counterfeiting Trade Agreement (ACTA): An Assessment, EXPO/B/INTA/FWC/2009-01/Lot7/12 (July 11, 2011).
The World Medicines Situation Report 2011: Medicine Prices, Availability, and AffordabilityWHO1.5 MiB2011
World Health Organization, The World Medicines Situation Report 2011: Medicine Prices, Availability, and Affordability, 3rd Edition, WHO/EMP/MIE/2011.2.1 (2011), http://apps.who.int/medicinedocs/documents/s18065en/s18065en.pdf.
Substandard/Spurious/Falsely-Labelled/Falsified/Counterfeit Medical ProductsReport by the Director General39.3 KiB2011
Report by the Director General, World Health Organization, Substandard/Spurious/Falsely-Labelled/Falsified/Counterfeit Medical Products, A64/16 (Mar. 24, 2011).
Measuring medicine prices, availability, affordability, and price componentsWHO4.4 MiB2008
World Health Organization, Measuring medicine prices, availability, affordability, and price components, 2d Edition, WHO/PSM/PAR/2008.3 (May 29, 2008), http://www.who.int/medicines/areas/access/OMS_Medicine_prices.pdf.
Bulletin, Access To AIDS Medicines Stumbles On Trade RulesWHO53.6 KiB2006
Press Release, World Health Organization, Bulletin of the World Health Organization: Access to AIDS medicines stumbles on trade rules (May 10, 2006), http://www.who.int/bulletin/volumes/84/5/news10506/en/index.html.
Rep. of the Special Rapporteur, Paul Hunt: AddendumU.N. Special Rapporteur Paul Hunt103.8 KiB2004.03.01
U.N. Special Rapporteur Paul Hunt, Economic, Social, and Cultural Rights: The right of everyone to the enjoyment of the highest attainable standard of physical and mental health: Rep. of the Special Rapporteur, Paul Hunt: Addendum, U.N. Doc. E/CN.4/2004/49/Add.1 (Mar. 1, 2004).
2009 UN Special Rapporteur Anand Grover, Promotion And Protection Of All Human Rights, . Including The Right To Development119.2 KiB
Name Author Size Date
Name Author Size Date
Presentation: Standing Committee on the Law of PatentsCarlos Correa330.5 KiB2011.05.17
Carlos Correa, Presentation: Standing Committee on the Law of Patents (May 17, 2011), http://keionline.org/node/1133.
Eye on the BallOxfam501.4 KiB2011.02.02
OXFAM, EYE ON THE BALL: MEDICINE REGULATION – NOT IP ENFORCEMENT – CAN BEST DELIVER QUALITY MEDICINES (2011), available at: http://www.oxfam.org/en/policy/eye-ball.
The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual PropertyGerman Velasquez379.4 KiB2011.01
German Velasquez, The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property (South Centre Research Papers No. 35, 2011) available at http://www.southcentre.org/index.php?option=com_content&view=article&id=1508%3Athe-right-to-health-and-medicines-the-case-of-recent-negotiations-on-the-global-strategy-on-public-health-innovation-and-intellectual-property&catid=31%3Ainnovation-and-access-to-knowledge&Itemid=310&lang=en.
Presentation: Intellectual Property and Access to Affordable Medicines: TRIPS PlusJudit R. Sanjuan289.5 KiB2011
Judit R. Sanjuan, Presentation: Intellectual Property and Access to Affordable Medicines: TRIPS Plus (May 17, 2011), http://keionline.org/node/1133.
Limitations on remedies as a TRIPS flexibilityJames Love54.0 KiB2011
James Love, Limitations on remedies as a TRIPS flexibility (May 17, 2011), http://keionline.org/node/1133.
The Secret Treaty: Anti-Counterfeiting Trade Agreement (ACTA) and Its Impact on Access to MedicinesCampaign for Access to Essential Medicines, Medicines Sans Frontieres220.8 KiB2010.11.19
CAMPAIGN FOR ACCESS TO ESSENTIAL MEDICINES, MEDECINS SANS FRONTIERES, THE SECRET TREATY: ANTI-COUNTERFEITING TRADE AGREEMENT (ACTA) AND ITS IMPACT ON ACCESS TO MEDICINES (2010), available at: http://www.msfaccess.org/resources/key-publications/key-publication-detail/?tx_ttnews%5Btt_news%5D=1654&cHash=77bc8bb088.
Open Letter to European Trade Commissioner Karel De GuchtMedecins Sans Frontieres68.0 KiB2010.11.08
Open Letter from Dr. Unni Karunakara, Int’l Council President, & Dr. Tido von Schoen-Angerer, Exec. Director, Medecins Sans Frontieres, to Karel De Gucht, European Trade Comm’r (Nov. 08, 2010) (on file with Medecins Sans Frontieres), available at: http://www.msf.org/msf/articles/2010/11/stop-the-spin-msf-open-letter-to-european-trade-commissioner-de-gucht.cfm.
Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special RapporteurPaul Hunt, Rajat Khosla87.5 KiB2010.09
Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the Former United Nations Special Rapporteur (2002–2008), THE PLOS MEDICINE DEBATE (PLoS Medicine), Sept. 2010, http://www.who.int/medicines/areas/human_rights/HuntPLOSMed_2010.pdf.
ACTA's Scope and Access to MedicinesPeter Maybarduk167.1 KiB2010
PETER MAYBARDUK, PUBLIC CITIZEN, ACTA’S SCOPE AND ACCESS TO MEDICINES (2010).
ACTA and the Drug Monopoly Enforcement Agenda: A windfall for big drug companies; higher medicine prices for allEssential Action100.7 KiB2009.07.27
ACTA and the Drug Monopoly Enforcement Agenda: A windfall for big drug companies; higher medicine prices for all, ESSENTIAL ACTION (July 27, 2009, 9:04 AM), http://www.essentialaction.org/access/index.php?/archives/213-ACTA-and-the-Drug-Monopoly-Enforcement-Agenda-A-windfall-for-big-drug-companies;-higher-medicine-prices-for-all.html.
Patents versus PatientsOxfam278.9 KiB2006.11.14
OXFAM, PATENTS VERSUS PATIENTS: FIVE YEARS AFTER THE DOHA DECLARATION (2006), available at: http://www.oxfam.org/en/policy/bp95_patentsvspatients_061114.

Your Name (required)

Your Email (required)

Subject

Your Message

A2M Document Submission

Select a document

Document Type

Document Name

Document Author

Document Description

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly

 Leave a Reply

(required)

(required)


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>